Astellas Pharma Inc. announced that at a meeting of its Board of Directors approved changes of its Representative Director, President and CEO and its management structure. Naoki Okamura will take over as Representative Director, new President and CEO with Kenji Yasukawa to be Representative Director, Chairman of the Board Effective April 1, 2023. Reason for Change: Astellas has been working on its Corporate Strategic Plan 2018 and Corporate Strategic Plan 2021 ("CSP2021 [2]") since fiscal year 2018, when Kenji Yasukawa was appointed as President and CEO, to realize its VISION "On the forefront of healthcare change to turn innovative science into VALUE for patients". During this time, Astellas overcame the patent cliff associated with the expiration of products exclusivity that had supported its growth in the past, and revenue has turned upward trend after bottoming out in fiscal year 2020. In addition, Astellas moved away from its past business model of creating products with a focus on specific disease areas and promoted a shift to the Focus Area approach of determining R&D areas from a multifaceted perspective, and is also making progress in developing new drug candidates that will drive future revenues. Fiscal year 2023 is the right time to go on the aggressive to further accelerate growth, and Naoki Okamura will take over as new President and CEO. Astellas decided it is best for it to consider and implement strategies for achieving CSP2021, which ends in fiscal year 2025 and long-term growth beyond that under the new leadership. The environment surrounding the company is changing rapidly, such as increasing geopolitical risks and changes
in the finances and markets of each country due to the COVID-19 crisis, but the new top management has the ability to flexible in response to such changes. Naoki Okamura - Date of Birth: September 18, 1962. Place of Birth: Shizuoka Prefecture - Career History: April 2022 Representative Director, Executive Vice President and Chief Strategy Officer (CStO), the Company (present post) March 2022 - Representative Director, Executive Vice President, Chief Strategy Officer and Chief Business Officer (CStO and CBO), the Company September 2021 - Representative Director, Executive Vice President, Chief Strategy Officer, Chief Financial Officer and Chief Business Officer (CStO & CFO, and CBO), the Company October 2019 - Representative Director, Executive Vice President, Chief Strategy Officer and Chief Financial Officer, (CStO & CFO), the Company June 2019 - Representative Director, Executive Vice President, Chief Strategy Officer (CStO), the Company April 2019 - Corporate Executive Vice President, Chief Strategy Officer (CStO), the Company April 2018 - Corporate Executive, Chief Strategy Officer (CStO), the Company June 2016 - Corporate Executive, Vice President, Corporate Planning, the Company April 2016 - Vice President, Corporate Planning, the Company July 2014 - Vice President, Licensing & Alliances, the Company April 2012 - Senior Vice President, Chief Strategy Officer, Astellas Pharma Europe Ltd. October 2010 - President & CEO, OSI Pharmaceuticals Inc. April 1986 Joined the Company - Education - March 1985 University of Tokyo, Faculty of Pharmacy. Kenji Yasukawa - Date of Birth: June 7, 1960. Place of Birth: Tokyo. Career History: April 2018 - Representative Director, President and CEO, the Company (present post)- June 2017 Representative Director, Executive Vice President, Chief Strategy Officer and Chief Commercial Officer, the Company - April 2017 Senior Corporate Executive, Senior Vice President, Chief Strategy Officer and Chief Commercial Officer, the Company - June 2012 Senior Corporate Executive, Senior Vice President and Chief Strategy Officer, the Company - April 2012 Corporate Executive, Senior Vice President and Chief Strategy Officer, the Company - April 2011 Corporate Executive, Vice President, Product & Portfolio Strategy, the Company - October 2010 Corporate Executive of the Company, Therapeutic Area Head, Urology, Astellas Pharma Global Development Inc. - June 2010 Corporate Executive of the Company, Therapeutic Area Head, Urology, Astellas Pharma Europe B.V. - April 2005 Vice President, Project Management, Urology, the Company - April 1986 Joined the Company (former Yamanouchi Pharmaceutical Co. Ltd.)- Education: July 2001 Showa University Graduate School of Pharmaceutical Sciences, Japan, Ph.D. in Pharmaceutical Sciences - March 1986 University of Tokyo, Master of Science, Agriculture.